Tan, W.W., Allred, J.B., Salim, M., et al. (2012) Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: A north central cancer treatment group trial. Clinical Breast Cancer, 12, 81-86.

曲妥珠单抗、帕妥珠单抗联合多西他赛对晚期三阳性乳腺癌一线治疗的临床疗效
Clinical Efficacy of Trastuzumab, Pertuzumab and Docetaxel as First-Line Treatment for Metastatic Triple-Positive Breast Cancer

曹 宇, 孙 萍   

临床医学进展Vol.12 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.1281125, August 23 2022

卡培他滨单药或联合方案治疗转移性乳腺癌临床疗效观察
Clinical Curative Effect Observation of the Treatment of Metastatic Breast Cancer (MBC) with Capecitabine Medicine or Combination Chemotherapy

李 杰, 李凤虎, 常建英, 李杰慧, 袁 佳, 刘诗苑, 冉 立    科研立项经费支持

临床医学进展Vol.4 No.4, 全文下载: PDF HTML DOI:10.12677/ACM.2014.44016, December 31 2014

扶正祛邪滋阴汤结合放化疗治疗三阴性乳腺癌的临床评价
Clinical Evaluation of Fuzhengquxieziyin Decoction Combined with Radiotherapy and Chemotherapy in the Treatment of Triple Negative Breast Cancer

赵 东, 斯晓芳, 苟小琳, 齐 萌    科研立项经费支持

世界肿瘤研究Vol.14 No.1, 全文下载: PDF HTML XML DOI:10.12677/WJCR.2024.141002, January 11 2024

曲妥珠单抗靶向治疗HER2阳性乳腺癌的研究进展
Research Progress of Trastuzumab Targeted Therapy for HER2-Positive Breast Cancer

胥世霜   

临床医学进展Vol.13 No.7, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1371686, July 27 2023

转移性三阴性乳腺癌临床治疗进展
Clinical Advances in the Treatment of Metastatic Triple Negative Breast Cancer

符 号, 史颖晨, 杨卫卫   

临床医学进展Vol.9 No.7, 全文下载: PDF HTML XML DOI:10.12677/ACM.2019.97134, July 25 2019

抗体–药物偶联物在HER2阳性乳腺癌治疗中的研究进展
Research Progress of Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer

古丽斯热·阿不都克里木, 赵 兵   

临床医学进展Vol.14 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.141256, January 30 2024